# Naproxen

NDC: 0054-3630
Generic name: Naproxen
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20210224

FDA application: ANDA074190

## Active ingredients

- NAPROXEN: 125 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-3630"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-3630
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5757b1a-62c9-4421-9794-6fb121ce9b7e